Industry Trends
An Analysis of Worldwide Prescription and OTC Sales by Technology
(2002 - 2012)
By Mark P. Mathieu
EvaluatePharma® calculates that worldwide pharmaceutical sales from biotechnology products increased 20%, to $94bn, in 2007.
Read more
|
Latest eNewsletters
eCliniqua
Site Solutions for All that Ails EDC
June 22, 2009
Predictive Biomedicine
Remodeling FDA; IBM's Cloud Computing; Entelos to Delist?
June 11,2009
|
 |
Sales Contacts
For advertising information contact: Alan El Faye
VP, Advertising Sales - Western US, Canada, Europe, Pacific Rim
213-300-3886
Kay O. Christopher
Regional Sales Manager, Advertising Sales - Eastern US, Midwest and India
860-693-2991
|
|
Link to Us!
You are welcome to link to articles on our website. Contact Allison Proffitt for details.
e-Prints & Reprints
To post a full article from Weekly Update or Bio-IT World on your website (not just a link), or for paper reprints, please contact:
Ashley Zander
The YGS Group
717-399-1900 ext.125
|
|
|
|
| IN THIS ISSUE |
 |
Will Regulated Product Submission (RPS) Trump eCTD? |
|
CLC bio to Launch High-Performance Computing ‘Genomics Machine’ at ISMB |
|
Microsoft Names Les Jordan as BioIT Alliance Director |
|
Cloud Storage Alternatives to Amazon and Google |
|
View Now
|
Work Faster Using Secure Web Conferencing...
View a complimentary Bio-IT World moderated web seminar that can help your organization leverage the power of secure Web conferencing for productivity enhancement in life science and healthcare. It includes expert commentary from Adobe and a video demonstration. Learn how this advanced technology can help you and your organization reach new levels of efficiency in drug development and healthcare related work. View seminar |
|
|
| |
| THIS WEEK IN BIO-IT |
| |
Will Regulated Product Submission (RPS) Trump eCTD?
By Ann Neuer
Just as the electronic common technical document (eCTD) is gaining traction as the required format for electronic regulatory submissions, the Food and Drug Administration (FDA) is changing the game. FDA is planning to implement an agency-wide standard known as Regulated Product Submission (RPS) that is expected to replace eCTD. Read more.
|
|
| |
CLC bio to Launch High-Performance Computing ‘Genomics Machine’ at ISMB
By Bio-IT World staff
Danish informatics company CLC bio will unveil the CLC 'Genomics Machine' at the Intelligent Systems for Molecular Biology (ISMB) conference in Stockholm next week, billed as the “first turnkey solution for analyzing and visualizing next-generation sequencing data,” including a hardware platform, pre-installed software, and an enterprise level database. Read more.
|
|
| |
Microsoft Names Les Jordan as BioIT Alliance Director
By Kevin Davies
Microsoft has appointed Les Jordan, industry chief technology strategist for Microsoft’s life sciences team, as the new director of the BioIT Alliance, succeeding Rudy Potenzone. In his first interview, Jordan indicated a bright future for the consortium, with priorities including the implementation of standards and more significant engagement with big pharma. Read more.
|
| |
| |
COMMENTARY
Cloud Storage Alternatives to Amazon and Google
By Sajai Krishnan
Cloud computing is in the press a lot these days. What's all the fuss about? To seasoned IT administrators, this looks like the latest shiny new thing that IT vendors are pushing. You can’t blame users who roll their eyes and think, “Here they go again.” Read more.
|
|
| |
|
|
| |
Bio-IT Briefs
Jun 17-23 | Full Stories
- PhaseForward releases InForm Global Trial Management
- Accelrys names Max Carnecchia CEO
- ParaScale offers cloud ECM
- Xyntek delivers spreadsheet control solutions
|
|
 |
| |
| |
| ELSEWHERE IN THE PRESS |
| |
FDA Approval of Novartis' Ilaris Validates Drug Repositioning
Last week's FDA approval of Ilaris, a biotech drug developed by Novartis for a rare autoimmune disease called Muckle-Wells disease, is a validation of a drug repositioning strategy and personalized medicine philosophy. Business Week
Virus Halts Orphan Drug Production at Genzyme Plant
Viral contamination has been detected at a Genzyme production facility in Boston, temporarily halting production of drugs for two orphan diseases, Gaucher and Fabry disease. Boston Globe
|
|
|
 |
|
LIFE SCIENCE JOBS
 Manager, Scientific Computing & Programming (Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland. In this role, you will lead the Bioinformatics & Analysis Group. Master’s or equivalent required. PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience. View complete job posting & apply: www.saic-frederick.com. Position #146945.
To have your job openings featured here, contact Lynn Cloonan for more information.
|
|
| |
|
|
| |
Insight Pharma Reports
Medicinal Chemistry for Drug Discovery Significance of Recent Trends
Author: Ken Rubenstein, Ph.D.
 Although the fundamental task of medicinal chemists has not changed drastically over time, the chemical and computational tools and perspectives at their disposal have advanced significantly. One in particular, fragment-based drug design, stands out as promising major improvements in research productivity. Medicinal Chemistry for Drug Discovery: Significance of Recent Trends reviews the state of the art and aims to determine the significance of technology and market trends in medicinal chemistry for advancing productivity in drug discovery. Read more.
|
|
| |
|
|
|
|
Understanding the Complete Picture of Genetic Variation
|
Herbert Auer, Director of the Functional Genomics Core, Institute for Research in Biomedicine is speaking at the 2009 Bio-IT World Europe meeting, 6-8 Oct in Hannover, Germany.
Auer's team obtained sequence information of 6.2 gigabases from two drosophila strains, resulting in 25 fold genomic coverage for each strain; this data set was used to highlight challenges of and solutions for understanding genetic variation from NextGen data.
Hear Auer preview his findings. Listen to the podcast.
Conference Tracks at Bio-IT World Europe are: Hardware for the Life Sciences; Bioinformatics for Genomics; IT Software for the Life Sciences; and Data Integration and Knowledge Management. Download a conference brochure today.
If you have questions, email managing editor Allison Proffitt at: aproffitt@healthtech.com
|
| |
|
| FEATURED CONTENT |
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers. This white paper provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents. (Sponsored by Thomson Reuters)
 Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Help your organization maintain control over vast and overwhelming streams of data and prepare for the future of sequencing through this informative paper. Download the paper (sponsored by BlueArc)
 Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development. Download the paper (sponsored by SAS)
 What’s Wrong with Biomarkers?
No one doubts biomarkers’ long-term value, but many obstacles remain. Read this in-depth analysis in which distinguished experts examine biomarker challenges, failures, barriers, and need for standards.
Download the Briefing (sponsored by Definiens)
 Protecting Intellectual Property
In this white paper we explore the issues facing patent creation and defence in the electronic age and discuss the tools and functionality required to protect innovation. Access the Paper (sponsored by IDBS)
To have your white paper featured here, contact Lynn Cloonan for more information.
|
|
| EXCLUSIVE WEBCAST |
Life Science Webcasts from Bio-IT World and Cambridge Healthtech Media Group
NEW!
Chris Dagdigian Talks Trends
At the Bio-IT World Conference & Expo, Chris Dagdigian talked about the old news, breaking news, and future of bio-IT. Get his perspective on what's overhyped and what's worth the buzz. View the webcast.
NEW!
The Future of Personal Genomics
An expert panel candidly discussed the future of personal genomics and what that means for both companies and consumers at the Bio-IT World Expo. Clifford Reid (Complete Genomics), Philip Reilly (3rd Rock Ventures), Dietrich Stephan (Navigenics), Robert Green (Boston University), John Halamka (Harvard Medical School), and Jorge Conde (Knome), give their unique perspectives on how this emerging industry could change medicine. View the webcast.
Boguski's Resounding Health
Mark Boguski is launching a new direct-to-consumer Internet search firm called Resounding Health and he tells Bio-IT World Editor, Kevin Davies, all about it. His goal is to create value-adding process networks to provide the most cost-effective management of chronic diseases in the near future. View the webcast.
Open Source Models for Personalized Medicine
Through the company he founded, CollabRx, Jay Tenenbaum aims to leverage the extraordinary untapped expertise and resources across the industry to empower individual patient health care through personalized research. View the webcast.
|
|
| Contact the Editor |
We invite your comments and feedback for this edition of Weekly Update.
Managing Editor
|
|
Follow
